Collegium Pharmaceutical
COLL
eBay
EBAY
Halozyme Therapeutics
HALO
SilverCrest Metals
SILV
Workday
WDAY
(Q3)Sep 30, 2018 | (Q2)Jun 30, 2018 | (Q1)Mar 31, 2018 | (FY)Dec 31, 2017 | (Q4)Dec 31, 2017 | (Q3)Sep 30, 2017 | (Q2)Jun 30, 2017 | (Q1)Mar 31, 2017 | (FY)Dec 31, 2016 | (Q4)Dec 31, 2016 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Cash, cash equivalents and short term investments | -80.77%159K | 24.32%506K | -55.39%364K | -61.76%681K | -61.76%681K | -68.46%827K | -83.26%407K | -93.77%816K | -77.58%1.78M | -77.58%1.78M |
-Cash and cash equivalents | -80.77%159K | 24.32%506K | -55.39%364K | -61.76%681K | -61.76%681K | -68.46%827K | -83.26%407K | -93.77%816K | -77.58%1.78M | -77.58%1.78M |
Receivables | -34.10%7.51M | -41.01%6.36M | -25.03%9.05M | -3.78%9.85M | -3.78%9.85M | -37.77%11.4M | -46.70%10.78M | -13.40%12.07M | -39.83%10.24M | -39.83%10.24M |
-Accounts receivable | -95.40%370K | -97.80%186K | -97.08%340K | -36.75%6.23M | -36.75%6.23M | -52.38%8.04M | -53.47%8.46M | -12.51%11.65M | -40.68%9.86M | -40.68%9.86M |
-Loans receivable | ---- | ---- | 633.59%9.63M | 846.86%3.62M | 846.86%3.62M | 134.08%3.36M | 57.05%3.21M | 110.75%1.31M | -4.50%382K | -4.50%382K |
-Notes receivable | --7.14M | --6.17M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Recievables adjustments allowances | --0 | --0 | -3.70%-924K | ---- | ---- | ---- | ---891K | ---891K | ---- | ---- |
Inventory | ---- | ---- | ---- | ---- | ---- | --0 | --0 | -88.83%65K | ---- | ---- |
Other current assets | -74.25%1.01M | -76.85%1.14M | -50.06%1.18M | 66.81%2.72M | 66.81%2.72M | -38.71%3.9M | 23.87%4.92M | -52.76%2.36M | -29.64%1.63M | -29.64%1.63M |
Total current assets | -46.21%8.68M | -50.30%8M | -30.81%10.59M | -27.69%13.3M | -27.69%13.3M | -41.68%16.13M | -40.34%16.1M | -53.05%15.31M | -35.60%18.39M | -35.60%18.39M |
Non current assets | ||||||||||
Net PPE | -11.86%104K | -52.10%80K | -93.29%31K | -87.28%44K | -87.28%44K | -80.97%118K | -75.83%167K | -33.04%462K | -47.50%346K | -47.50%346K |
-Gross PPE | -35.79%1.01M | -38.47%971K | -66.26%909K | -52.56%1M | -52.56%1M | -41.19%1.58M | -40.72%1.58M | 4.62%2.69M | -14.16%2.11M | -14.16%2.11M |
-Accumulated depreciation | 37.72%-908K | 36.85%-891K | 60.66%-878K | 45.75%-957K | 45.75%-957K | 29.22%-1.46M | 28.41%-1.41M | -18.41%-2.23M | 1.95%-1.76M | 1.95%-1.76M |
Goodwill and other intangible assets | -93.39%1.14M | -93.15%1.2M | -95.50%1.25M | -89.34%2.66M | -89.34%2.66M | -58.07%17.24M | -57.21%17.44M | -34.14%27.85M | -38.22%24.94M | -38.22%24.94M |
-Goodwill | ---- | ---- | ---- | --0 | --0 | -59.34%10.19M | -58.40%10.19M | -32.80%17.07M | -28.20%16.99M | -28.20%16.99M |
-Other intangible assets | -83.85%1.14M | -83.53%1.2M | -88.37%1.25M | -66.57%2.66M | -66.57%2.66M | -56.10%7.05M | -55.42%7.26M | -36.17%10.78M | -52.40%7.96M | -52.40%7.96M |
Investments and advances | --0 | --0 | --0 | --340K | --340K | -56.24%340K | -55.84%340K | ---- | --0 | --0 |
Other non current assets | -95.00%8K | -21.72%908K | 388.17%908K | -98.93%116K | -98.93%116K | -35.22%160K | -91.94%1.16M | -98.49%186K | -50.15%10.89M | -50.15%10.89M |
Total non current assets | -92.99%1.25M | -88.58%2.18M | -92.31%2.19M | -91.27%3.16M | -91.27%3.16M | -58.24%17.86M | -66.25%19.11M | -49.15%28.5M | -43.18%36.18M | -43.18%36.18M |
Total assets | -70.79%9.93M | -71.07%10.19M | -70.82%12.79M | -69.84%16.46M | -69.84%16.46M | -51.74%33.99M | -57.89%35.21M | -50.58%43.81M | -40.83%54.57M | -40.83%54.57M |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Payables | -57.82%3.92M | -54.59%4.43M | -57.31%4.3M | -28.33%4.67M | -28.33%4.67M | -22.17%9.28M | -1.12%9.75M | 30.55%10.07M | -24.15%6.51M | -24.15%6.51M |
-accounts payable | -58.03%3.86M | -54.84%4.38M | -57.36%4.27M | -27.98%4.65M | -27.98%4.65M | -22.77%9.19M | -1.26%9.7M | 41.72%10.01M | -18.57%6.46M | -18.57%6.46M |
-Total tax payable | -37.23%59K | -9.43%48K | -48.44%33K | -71.70%15K | -71.70%15K | 224.14%94K | 35.90%53K | -90.20%64K | -91.88%53K | -91.88%53K |
Current accrued expenses | -61.94%5.21M | -58.94%5.07M | -62.59%4.33M | -17.10%8.01M | -17.10%8.01M | 9.77%13.69M | 2.20%12.34M | -4.82%11.58M | 19.14%9.66M | 19.14%9.66M |
Current debt and capital lease obligation | -70.25%8.16M | -71.43%9.94M | -69.50%10.58M | -63.63%11.2M | -63.63%11.2M | 60.24%27.41M | 105.29%34.78M | 122.97%34.68M | 105.04%30.8M | 105.04%30.8M |
-Current debt | -70.25%8.16M | -71.43%9.94M | -69.50%10.58M | -63.63%11.2M | -63.63%11.2M | 60.24%27.41M | 105.29%34.78M | 122.97%34.68M | 105.04%30.8M | 105.04%30.8M |
Current deferred liabilities | -78.51%867K | -81.35%914K | -84.79%534K | 64.82%3.21M | 64.82%3.21M | 3.44%4.03M | 39.56%4.9M | -17.26%3.51M | -62.16%1.95M | -62.16%1.95M |
Other current liabilities | 92.07%5.43M | 93.45%6.11M | 73.16%5.99M | -24.39%6.72M | -24.39%6.72M | 31.32%2.83M | -50.84%3.16M | -60.44%3.46M | 2,051.09%8.88M | 2,051.09%8.88M |
Current liabilities | -58.82%23.58M | -59.25%26.46M | -59.35%25.73M | -41.52%33.8M | -41.52%33.8M | 20.37%57.24M | 33.02%64.93M | 30.74%63.3M | 44.68%57.8M | 44.68%57.8M |
Non current liabilities | ||||||||||
Long term debt and capital lease obligation | ---- | ---- | -87.82%269K | -89.92%1.06M | -89.92%1.06M | -95.71%1.17M | -94.31%2.37M | -93.91%2.21M | -72.71%10.49M | -72.71%10.49M |
-Long term debt | ---- | ---- | -87.82%269K | -89.92%1.06M | -89.92%1.06M | -95.71%1.17M | -94.31%2.37M | -93.91%2.21M | -72.71%10.49M | -72.71%10.49M |
Non current deferred liabilities | -89.59%56K | -90.73%56K | -92.04%60K | -76.15%239K | -76.15%239K | -46.31%538K | -38.74%604K | -19.19%754K | 10.23%1M | 10.23%1M |
Derivative product liabilities | 913.67%17.13M | 355.22%15.32M | 603.96%15.45M | 1,165.27%16.65M | 1,165.27%16.65M | -45.38%1.69M | -60.23%3.37M | -71.78%2.2M | -92.32%1.32M | -92.32%1.32M |
Preferred securities outside stock equity | --0 | --2.61M | --3.86M | --3.91M | --3.91M | ---- | ---- | ---- | --0 | --0 |
Other non current liabilities | --856K | --887K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Total non current liabilities | 431.61%18.04M | 197.79%18.87M | 280.77%19.64M | 70.62%21.86M | 70.62%21.86M | -89.15%3.39M | -87.60%6.34M | -88.53%5.16M | -77.32%12.81M | -77.32%12.81M |
Total liabilities | -31.36%41.62M | -36.39%45.33M | -33.73%45.37M | -21.18%55.66M | -21.18%55.66M | -23.08%60.64M | -28.68%71.26M | -26.70%68.46M | -26.77%70.61M | -26.77%70.61M |
Shareholders'equity | ||||||||||
Share capital | -46.15%21K | -60.00%4K | -95.83%2K | 4,500.00%92K | 4,500.00%92K | 680.00%39K | 233.33%10K | 2,300.00%48K | -33.33%2K | -33.33%2K |
-common stock | -46.15%21K | -60.00%4K | -95.83%2K | 4,500.00%92K | 4,500.00%92K | 680.00%39K | 233.33%10K | 2,300.00%48K | -33.33%2K | -33.33%2K |
-Preferred stock | --0 | --0 | --0 | --0 | --0 | --0 | ---- | ---- | --0 | --0 |
Retained earnings | -6.17%-191.81M | -10.37%-193.33M | -15.23%-188.06M | -29.76%-193.32M | -29.76%-193.32M | -30.77%-180.66M | -24.92%-175.16M | -28.70%-163.2M | -21.62%-148.98M | -21.62%-148.98M |
Paid-in capital | 5.02%160.71M | 14.26%158.69M | 12.89%155.99M | 18.09%154.54M | 18.09%154.54M | 19.87%153.03M | 12.69%138.89M | 13.74%138.18M | 11.18%130.87M | 11.18%130.87M |
Less: Treasury stock | 0.00%2K | 0.00%2K | 100.00%2K | 100.00%2K | 100.00%2K | 100.00%2K | 100.00%2K | 0.00%1K | --1K | --1K |
Other equity interest | -95.20%37K | 3,600.00%37K | 1,750.00%37K | -97.86%37K | -97.86%37K | -55.36%771K | -99.61%1K | -99.23%2K | 566.80%1.73M | 566.80%1.73M |
Total stockholders'equity | -15.72%-31.05M | 4.59%-34.6M | -28.25%-32.02M | -135.90%-38.65M | -135.90%-38.65M | -206.00%-26.83M | -117.03%-36.26M | -394.46%-24.97M | -261.56%-16.39M | -261.56%-16.39M |
Noncontrolling interests | -464.41%-645K | -368.29%-550K | -271.17%-558K | -260.06%-549K | -260.06%-549K | -50.00%177K | -48.49%205K | 2.84%326K | 3.31%343K | 3.31%343K |
Total equity | -18.91%-31.69M | 2.52%-35.15M | -32.21%-32.58M | -144.36%-39.2M | -144.36%-39.2M | -216.77%-26.65M | -121.07%-36.06M | -420.68%-24.64M | -281.98%-16.04M | -281.98%-16.04M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |